This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Many forms of orthostatic intolerance (OI) involve impaired regulation of CBF in the upright posture, which results in disabling symptoms that decrease quality of life. These result in diagnoses such as postural orthostatic tachycardia syndrome and orthostatic hypotension.
Recurrent symptomatic supraventricular tachycardia (SVT) can significantly affect patients’ quality of life and is a common cause of hospitalizations in the US. In light of its outstanding risk/benefit profile, catheter ablation (CA) is nowadays the recommended therapy for SVT and can be performed during hospitalization.
Patients with inappropriate sinus tachycardia (IST) have a significant change in quality of life and are unable to tolerate medications due to side effects.
This ultimately resulted in severe coronary artery occlusion, myocardial scarring and frequent episodes of ventricular tachycardia, which had a significant impact on the patient's quality of life. The objective of this report was to enhance clinicians' awareness of embolism susceptibility.
In patients with implantable cardioverter defibrillator (ICD) inappropriate device therapy (IDT) is associated with worse outcomes and reduced quality of life (QoL). IDT is not rarely induced by misinterpretation of supraventricular tachycardia, detected by the ICD as atrial high rate episodes (AHRE).
Arrhythmias : A leadless pacemaker-defibrillator system provides antitachycardia pacing for ventricular tachycardia in patients with subcutaneous ICDs. Overcoming status quo bias and embracing the latest evidence-based practices are essential steps toward delivering high-quality, personalized care in cardiometabolic medicine.
POTS stands for postural orthostatic tachycardia syndrome. Let’s call it Postural Orthostatic Tachycardia Syndrome – that’s not really a diagnosis – it’s just a medical jargon filled term for what the patient has just told us. What is POTS? When you examine them, the heart rate can be found to be excessively fast.
It works by briefly delivering pacing pulses to the heart at a rate faster than the tachycardia. We also now have increased evidence for the effectiveness and tolerability of anti-tachycardia pacing, rather than just shocks.
Abstract Aims This prospective, cross-sectional study aimed to identify sex-based differences in diagnostic and symptom experiences in postural orthostatic tachycardia syndrome (POTS). Health-related quality of life was assessed using the EuroQol 5 Dimension tool. years; P = 0.010) and were 1.2.7 vs males, 43.7 P = 0.485).
Methods The primary effectiveness endpoint (PEE) was 12-month freedom from documented atrial fibrillation/atrial flutter/atrial tachycardia plus freedom from acute procedural failure, nonstudy catheter failure, repeat ablation failure, direct current cardioversion (DCCV), and Class I/III antiarrhythmic drug (AAD) failure.
The main secondary study endpoints are all-cause mortality, cardiovascular mortality, incidence of implantable cardioverter-defibrillator (ICD) therapy, hospitalizations, quality of life, time to first ICD therapy, number of device-detected ventricular tachycardia/ventricular fibrillation episodes, left ventricular function, and exercise tolerance.
ABSTRACT Typical atrial flutter (AFL), defined as cavotricuspid isthmus (CTI)-dependent macro-re-entrant atrial tachycardia, often causes debilitating symptoms, and is associated with increased incidence of atrial fibrillation, stroke, heart failure, and death.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content